Literature DB >> 26667487

Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment.

Daniel Delitto1, Dongyu Zhang1, Song Han1, Brian S Black1, Andrea E Knowlton2, Adrian C Vlada1, George A Sarosi3, Kevin E Behrns1, Ryan M Thomas3, Xiaomin Lu4, Chen Liu5, Thomas J George6, Steven J Hughes1, Shannon M Wallet2, Jose G Trevino7.   

Abstract

PURPOSE: The relationship between smoking and pancreatic cancer biology, particularly in the context of the heterogeneous microenvironment, remains incompletely defined. We hypothesized that nicotine exposure would lead to the augmentation of paracrine growth factor signaling between tumor-associated stroma (TAS) and pancreatic cancer cells, ultimately resulting in accelerated tumor growth and metastasis. EXPERIMENTAL
DESIGN: The effect of tobacco use on overall survival was analyzed using a prospectively maintained database of surgically resected patients with pancreatic cancer. Nicotine exposure was evaluated in vitro using primary patient-derived TAS and pancreatic cancer cells independently and in coculture. Nicotine administration was then assessed in vivo using a patient-derived pancreatic cancer xenograft model.
RESULTS: Continued smoking was associated with reduced overall survival after surgical resection. In culture, nicotine-stimulated hepatocyte growth factor (HGF) secretion in primary patient-derived TAS and nicotine stimulation was required for persistent pancreatic cancer cell c-Met activation in a coculture model. c-Met activation in this manner led to the induction of inhibitor of differentiation-1 (Id1) in pancreatic cancer cells, previously established as a mediator of growth, invasion and chemoresistance. HGF-induced Id1 expression was abrogated by both epigenetic and pharmacologic c-Met inhibition. In patient-derived pancreatic cancer xenografts, nicotine treatment augmented tumor growth and metastasis; tumor lysates from nicotine-treated mice demonstrated elevated HGF expression by qRT-PCR and phospho-Met levels by ELISA. Similarly, elevated levels of phospho-Met in surgically resected pancreatic cancer specimens correlated with reduced overall survival.
CONCLUSIONS: Taken together, these data demonstrate a novel, microenvironment-dependent paracrine signaling mechanism by which nicotine exposure promotes the growth and metastasis of pancreatic cancer. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26667487      PMCID: PMC4818664          DOI: 10.1158/1078-0432.CCR-15-1256

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  58 in total

1.  Prognostic assessment of different lymph node staging methods for pancreatic cancer with R0 resection: pN staging, lymph node ratio, log odds of positive lymph nodes.

Authors:  Marco La Torre; Giuseppe Nigri; Niccolò Petrucciani; Marco Cavallini; Paolo Aurello; Giulia Cosenza; Genoveffa Balducci; Vincenzo Ziparo; Giovanni Ramacciato
Journal:  Pancreatology       Date:  2014-06-14       Impact factor: 3.996

Review 2.  c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer.

Authors:  Daniel Delitto; Eva Vertes-George; Steven J Hughes; Kevin E Behrns; Jose G Trevino
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  c-Met is a marker of pancreatic cancer stem cells and therapeutic target.

Authors:  Chenwei Li; Jing-Jiang Wu; Mark Hynes; Joseph Dosch; Bedabrata Sarkar; Theodore H Welling; Marina Pasca di Magliano; Diane M Simeone
Journal:  Gastroenterology       Date:  2011-08-22       Impact factor: 22.682

4.  Pancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors α3, α5, and α7.

Authors:  Mohammed H Al-Wadei; Hussein A N Al-Wadei; Hildegard M Schuller
Journal:  Mol Cancer Res       Date:  2011-12-21       Impact factor: 5.852

Review 5.  Patient-derived tumour xenografts as models for oncology drug development.

Authors:  John J Tentler; Aik Choon Tan; Colin D Weekes; Antonio Jimeno; Stephen Leong; Todd M Pitts; John J Arcaroli; Wells A Messersmith; S Gail Eckhardt
Journal:  Nat Rev Clin Oncol       Date:  2012-04-17       Impact factor: 66.675

Review 6.  MET signalling: principles and functions in development, organ regeneration and cancer.

Authors:  Livio Trusolino; Andrea Bertotti; Paolo M Comoglio
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

7.  The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: antiangiogenic implications in pancreatic cancer.

Authors:  Mishaal B Patel; Srinivasa P Pothula; Zhihong Xu; Alexandra K Lee; David Goldstein; Romano C Pirola; Minoti V Apte; Jeremy S Wilson
Journal:  Carcinogenesis       Date:  2014-05-29       Impact factor: 4.944

8.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

Review 9.  Electronic cigarettes and nicotine clinical pharmacology.

Authors:  Megan J Schroeder; Allison C Hoffman
Journal:  Tob Control       Date:  2014-05       Impact factor: 7.552

10.  Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer.

Authors:  Hong Hua Yan; Kyung Hee Jung; Mi Kwon Son; Zhenghuan Fang; Soo Jung Kim; Ye-Lim Ryu; Juyoung Kim; Mi-Hyun Kim; Soon-Sun Hong
Journal:  Oncotarget       Date:  2014-10-15
View more
  11 in total

1.  Cigarette Smoking and Pancreatic Cancer Survival.

Authors:  Chen Yuan; Vicente Morales-Oyarvide; Ana Babic; Clary B Clish; Peter Kraft; Ying Bao; Zhi Rong Qian; Douglas A Rubinson; Kimmie Ng; Edward L Giovannucci; Shuji Ogino; Meir J Stampfer; John Michael Gaziano; Howard D Sesso; Barbara B Cochrane; JoAnn E Manson; Charles S Fuchs; Brian M Wolpin
Journal:  J Clin Oncol       Date:  2017-03-30       Impact factor: 44.544

2.  Nicotine-induced miR-21-3p promotes chemoresistance in lung cancer by negatively regulating FOXO3a.

Authors:  Yong-Qing Zhang; Rui-Lin Chen; Li-Qun Shang; Shu-Mei Yang
Journal:  Oncol Lett       Date:  2022-06-14       Impact factor: 3.111

3.  Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study.

Authors:  Qiwen Ben; Jie Zhong; Jian Fei; Haitao Chen; Lifen Yv; Jihong Tan; Yaozong Yuan
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

Review 4.  The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives.

Authors:  Bao Quoc Lam; Sushant K Shrivastava; Anju Shrivastava; Sharmila Shankar; Rakesh K Srivastava
Journal:  J Cell Mol Med       Date:  2020-05-26       Impact factor: 5.310

Review 5.  Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.

Authors:  Michael Orth; Philipp Metzger; Sabine Gerum; Julia Mayerle; Günter Schneider; Claus Belka; Maximilian Schnurr; Kirsten Lauber
Journal:  Radiat Oncol       Date:  2019-08-08       Impact factor: 3.481

6.  Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia.

Authors:  Patrick W Underwood; Dong Yu Zhang; Miles E Cameron; Michael H Gerber; Daniel Delitto; Michael U Maduka; Kyle J Cooper; Song Han; Steven J Hughes; Sarah M Judge; Andrew R Judge; Jose G Trevino
Journal:  Cancers (Basel)       Date:  2020-02-01       Impact factor: 6.639

7.  Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patients.

Authors:  Shuisheng Zhang; Chengfeng Wang; Huang Huang; Qinglong Jiang; Dongbing Zhao; Yantao Tian; Jie Ma; Wei Yuan; Yuemin Sun; Xu Che; Jianwei Zhang; Haibo Chen; Yajie Zhao; Yunmian Chu; Yawei Zhang; Yingtai Chen
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

8.  Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer.

Authors:  Verena M Throm; David Männle; Thomas Giese; Andrea S Bauer; Matthias M Gaida; Juergen Kopitz; Thomas Bruckner; Konstanze Plaschke; Svetlana P Grekova; Klaus Felix; Thilo Hackert; Nathalia A Giese; Oliver Strobel
Journal:  Oncotarget       Date:  2018-01-24

Review 9.  From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma.

Authors:  Christopher Montemagno; Shamir Cassim; Jacques Pouyssegur; Alexis Broisat; Gilles Pagès
Journal:  Int J Mol Sci       Date:  2020-06-06       Impact factor: 5.923

10.  A nicotine-induced positive feedback loop between HIF1A and YAP1 contributes to epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma.

Authors:  Qiwen Ben; Wei An; Yunwei Sun; Aihua Qian; Jun Liu; Duowu Zou; Yaozong Yuan
Journal:  J Exp Clin Cancer Res       Date:  2020-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.